Vincent, A., Pettingill, P., Pettingill, R., Lang, B., Birch, R., Waters, P., . . . Kiernan, M. C. (2018). Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia. JAMA Neurol.
Styl cytowania ChicagoVincent, Angela, et al. "Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia." JAMA Neurol 2018.
Styl cytowania MLAVincent, Angela, et al. "Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia." JAMA Neurol 2018.